Micro- and nanoscale biosensing technologies for early diagnosis of Parkinson’s disease
Microchimica Acta · 2025
DOI: 10.1007/s00604-025-07505-2 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Microchimica Acta, 2025. Verfasst von Tejas Nikam und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research, Raebareli (NIPER-R), Lucknow, Uttar Pradesh, 226002, India. Hauptthemen laut MEDLINE: Parkinson Disease, Biosensing Techniques. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 292 Literaturangaben. Gefördert von: Department of Biotechnology, Ministry of Science and Technology, India, National Institute of Pharmaceutical Education and Research, Raebareli.
Abstract (Originalsprache)
Parkinson's disease (PD), the second most prevalent neurodegenerative disorder, remains challenging to diagnose at its earliest stages due to the absence of definitive biomarkers and overlapping clinical features with other synucleinopathies, thereby delaying therapeutic intervention and effective disease management. This review provides an integrative evaluation of established and emerging approaches for detecting PD-specific biomarkers in biofluids and tissues with high sensitivity and specificity. Conventional assays such as seed amplification techniques, proximity ligation and extension methods, bead-based microarrays, and immunoassays including ELISA, electrochemiluminescence, and SIMOA are examined alongside their performance metrics and inherent limitations. We then highlight next-generation micro- and nanoscale biosensing platforms, including nanopore-based resistive pulse sensing, surface plasmon resonance (SPR), surface-enhanced Raman spectroscopy (SERS), field-effect transistors (FETs), electrochemical sensors, and lateral flow assays (LFAs), which are capable of ultrasensitive detection at nano- to attomolar concentrations. Particular emphasis is given to nucleic acid-based technologies such as aptasensors, genosensors, and CRISPR/Cas systems for their exceptional molecular recognition, programmable signal outputs, and portability. The potential of artificial intelligence and machine learning tools (e.g., SVM, RF, DNN) to improve biomarker interpretation, enable multiplexed analysis, and facilitate real-time monitoring is also discussed. Finally, we outline key translational challenges, including assay standardization, clinical validation, scalability, integration into wearable and point-of-care devices, and regulatory hurdles towards the development of robust, clinically deployable diagnostic platforms for early PD detection and monitoring.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research, Raebareli (NIPER-R), Lucknow, Uttar Pradesh, 226002, India.
- Department of Biotechnology, National Institute of Pharmaceutical Education and Research, Raebareli (NIPER-R), Lucknow, Uttar Pradesh, 226002, India.
- Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research, Raebareli (NIPER-R), Lucknow, Uttar Pradesh, 226002, India. shubhini.saraf@gmail.com.
- Department of Biotechnology, National Institute of Pharmaceutical Education and Research, Raebareli (NIPER-R), Lucknow, Uttar Pradesh, 226002, India. rf.saurabh.awasthi@niperrbl.ac.in.
Förderung
- Department of Biotechnology, Ministry of Science and Technology, India
- National Institute of Pharmaceutical Education and Research, Raebareli
Zitieren
APA
Nikam, T., Rana, A., Saraf, S. A., & Awasthi, S. (2025). Micro- and nanoscale biosensing technologies for early diagnosis of Parkinson’s disease. Microchimica Acta. https://doi.org/10.1007/s00604-025-07505-2
Vancouver
Nikam T, Rana A, Saraf SA, Awasthi S. Micro- and nanoscale biosensing technologies for early diagnosis of Parkinson’s disease. Microchimica Acta. 2025. doi:10.1007/s00604-025-07505-2
BibTeX
@article{Nikam2025,
author = {Nikam, Tejas and Rana, Anika and Saraf, Shubhini A and Awasthi, Saurabh},
title = {Micro- and nanoscale biosensing technologies for early diagnosis of Parkinson’s disease},
journal = {Microchimica Acta},
year = {2025},
doi = {10.1007/s00604-025-07505-2}
}
EUVIMED